SYRE - CIK 0001636282
Spyre Therapeutics, Inc. has filed 762 documents with the SEC between 2015 and 2026. The most frequent type is insider trade (195 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider sale notice | 144 | 2025-11-03 | - |
| SCHEDULE 13D/A | - | 2025-10-17 | - |
| Major company event | 8-K | 2025-10-15 | 2025-10-13 |
| Prospectus supplement | 424B5 | 2025-10-14 | - |
| Prospectus supplement | 424B5 | 2025-10-14 | - |
| Major company event | 8-K | 2025-10-14 | 2025-10-14 |
| Insider trade | 4 | 2025-09-03 | 2025-09-02 |
| Employee stock plan | S-8 | 2025-08-05 | - |
| Major company event | 8-K | 2025-08-05 | 2025-08-05 |
| Quarterly report | 10-Q | 2025-08-05 | 2025-06-30 |
| SCHEDULE 13G | - | 2025-07-29 | - |
| SCHEDULE 13G/A | - | 2025-07-16 | - |
| Major company event | 8-K | 2025-06-17 | 2025-06-17 |
| Insider trade | 4 | 2025-06-02 | 2025-05-29 |
| Insider trade | 4 | 2025-06-02 | 2025-05-29 |
| Insider trade | 4 | 2025-06-02 | 2025-05-29 |
| Insider trade | 4 | 2025-06-02 | 2025-05-29 |
| Insider trade | 4 | 2025-06-02 | 2025-05-29 |
| Insider trade | 4 | 2025-06-02 | 2025-05-29 |
| Major company event | 8-K | 2025-06-02 | 2025-05-29 |
| SEC correspondence | UPLOAD | 2025-06-02 | - |
| Company correspondence | CORRESP | 2025-05-21 | - |
| SEC correspondence | UPLOAD | 2025-05-09 | - |
| Major company event | 8-K | 2025-05-08 | 2025-05-08 |
| Quarterly report | 10-Q | 2025-05-08 | 2025-03-31 |
| SCHEDULE 13G | - | 2025-05-01 | - |
| Annual report to shareholders | ARS | 2025-04-14 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-14 | - |
| Proxy statement | DEF 14A | 2025-04-14 | 2025-05-29 |
| EFFECT | - | 2025-03-13 | - |
| EFFECT | - | 2025-03-07 | - |
| POS AM | - | 2025-03-07 | - |
| Major company event | 8-K | 2025-03-06 | 2025-02-28 |
| Company correspondence | CORRESP | 2025-03-05 | - |
| SEC correspondence | UPLOAD | 2025-03-04 | - |
| Employee stock plan | S-8 | 2025-02-27 | - |
| Major company event | 8-K | 2025-02-27 | 2025-02-27 |
| Annual report | 10-K | 2025-02-27 | 2024-12-31 |
| Securities registration | S-3 | 2025-02-27 | - |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| Insider trade | 4 | 2025-01-17 | 2025-01-15 |
| Insider trade | 4 | 2025-01-17 | 2025-01-15 |
| Insider trade | 4 | 2025-01-17 | 2025-01-15 |
| Insider trade | 4 | 2025-01-17 | 2025-01-15 |
| Insider trade | 4 | 2025-01-14 | 2025-01-10 |
| Major company event | 8-K | 2025-01-13 | 2025-01-13 |
| Major company event | 8-K | 2024-11-19 | 2024-11-18 |
| Prospectus supplement | 424B5 | 2024-11-19 | - |